2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
François MachKonstantinos C. KoskinasJeanine E. Roeters van LennepLâle TokgözoğluLina BadimónColin BaigentMarianne BennChristoph J. BinderAlberico L. CatapanoGuy De BackerVictoria DelgadoNatalia FabinBrian A. FerenceIan GrahamUlf LandmesserBorislava MihaylovaBørge G. NordestgaardDimitrios RichterMarc S. Sabatine
No abstract yet
We only have this paper's title and publication details.
Read it at the sourceKey expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias marks a significant evolution in cardiovascular risk prevention, and it delivers nothing short of a paradigm shift. Incorporating new evidence from major trials up to March 2025, this update moves decisively towards a more personalized, aggressive, and earlier interventional approach.”
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Mach et al. (2025) studied this question.